CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Vilacto Bio Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Vilacto Bio Inc
4955 S Durango Dr Ste 165
Phone: (646) 875-5747p:646 875-5747 LAS VEGAS, NV  89113  United States

This company is no longer actively traded on any major stock exchange.

Business Summary
Vilacto Bio Inc., formerly Zlato Inc., is a biotechnology company engaged in the business of skincare products. The Company has developed Lactoactive, which is processing of colostrum combined with hyaluronic acid. Lactoactive contains hyaluronic acid, which penetrates the skin, regenerates damaged skin cells and restores elasticity. The Company provides treatment for various diseases, including inflammatory disorders & anti-inflammatory treatments, immune system factors, psoriasis, vitiligo, autoimmune related skin conditions, systemic lupus erythematosus (SLE) disease, blistering skin disease and diabetic ulcers disease. The Company sells its products under the name Vilact. The Company also sells its products through its Website www.vilactobio.com. The Company has operations in New York in the United States, Naestved in Denmark and Lithuania.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/20193/31/2019YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
President, Chief Executive Officer, Treasurer, Secretary, Director GertAndersen 2/24/2017 2/24/2017
Chief Operations Officer PernilleSteenfat 43 4/10/2017 4/10/2017
Chief Scientific Officer PoulMadsen 55 4/10/2017 4/10/2017

Business Names
Business Name
Pharma GP APS
VIBI
ZFLO
ZFLOD

General Information
Number of Employees: 1 (As of 3/31/2013)
Outstanding Shares: 2,137,022,424 (As of 8/19/2019)
Stock Exchange: OTC


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023